Experimental models of endocrine responsive breast cancer: strengths, limitations, and use

Breast cancers characterized by expression of estrogen receptor-alpha (ER; ESR1) represent approximately 70% of all new cases and comprise the largest molecular subtype of this disease. Despite this high prevalence, the number of adequate experimental models of ER+ breast cancer is relatively limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Robert, Jones, Brandon C., Sevigny, Catherine M., Hilakivi-Clarke, Leena A., Sengupta, Surojeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442978/
https://www.ncbi.nlm.nih.gov/pubmed/34532657
http://dx.doi.org/10.20517/cdr.2021.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442978/
https://www.ncbi.nlm.nih.gov/pubmed/34532657
http://dx.doi.org/10.20517/cdr.2021.33

Ejemplares similares